# A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001

> **NCT00382408** · PHASE3 · COMPLETED · sponsor: **Duramed Research** · enrollment: 4040 (actual)

## Conditions studied

- Respiratory Tract Diseases

## Interventions

- **BIOLOGICAL:** DR-5001
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00382408
- **Lead sponsor:** Duramed Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 4040 (ACTUAL)
- **Last updated:** 2017-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382408, "A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00382408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*